SI0813876T1 - Cyclosporin-containing soft capsule preparations - Google Patents

Cyclosporin-containing soft capsule preparations

Info

Publication number
SI0813876T1
SI0813876T1 SI9730334T SI9730334T SI0813876T1 SI 0813876 T1 SI0813876 T1 SI 0813876T1 SI 9730334 T SI9730334 T SI 9730334T SI 9730334 T SI9730334 T SI 9730334T SI 0813876 T1 SI0813876 T1 SI 0813876T1
Authority
SI
Slovenia
Prior art keywords
cyclosporin
soft capsule
containing soft
capsule preparations
preparations
Prior art date
Application number
SI9730334T
Other languages
English (en)
Slovenian (sl)
Inventor
Jong Soo Woo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI0813876T1 publication Critical patent/SI0813876T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Peptides Or Proteins (AREA)
SI9730334T 1996-06-19 1997-06-05 Cyclosporin-containing soft capsule preparations SI0813876T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019960022417A KR0183449B1 (ko) 1996-06-19 1996-06-19 사이클로스포린-함유 연질캅셀제
EP97109152A EP0813876B1 (de) 1996-06-19 1997-06-05 Cyclosporin enthaltende Weichkapselpräparate

Publications (1)

Publication Number Publication Date
SI0813876T1 true SI0813876T1 (en) 2002-10-31

Family

ID=19462548

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730334T SI0813876T1 (en) 1996-06-19 1997-06-05 Cyclosporin-containing soft capsule preparations

Country Status (16)

Country Link
EP (1) EP0813876B1 (de)
JP (2) JP2855135B2 (de)
KR (1) KR0183449B1 (de)
CN (1) CN1180840C (de)
AR (1) AR013586A1 (de)
AT (1) ATE214937T1 (de)
CO (1) CO4970826A1 (de)
DE (1) DE69711267T2 (de)
DK (1) DK0813876T3 (de)
ES (1) ES2175217T3 (de)
ID (1) ID18517A (de)
PE (1) PE97198A1 (de)
PL (1) PL188986B1 (de)
PT (1) PT813876E (de)
SI (1) SI0813876T1 (de)
ZA (1) ZA975448B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980073479A (ko) * 1997-03-14 1998-11-05 한스루돌프하우스, 니콜케르커 사이클로스포린-함유 연질캅셀제
KR19990047897A (ko) * 1997-12-05 1999-07-05 김충환 사이클로스포린 함유 약학적 조성물
CN1236813C (zh) 1998-12-11 2006-01-18 药品处理公司 水难溶性药物的自乳化组合物
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
KR100533460B1 (ko) * 2002-07-20 2005-12-08 대화제약 주식회사 난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
GB2391472B (en) * 2002-08-02 2004-12-08 Satishchandra Punambhai Patel Pharmaceutical compositions
GB2391473B (en) * 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
CA2520660C (en) * 2003-03-28 2013-08-20 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
EP2079456B1 (de) * 2007-04-04 2012-12-05 Sigmoid Pharma Limited Pharmazeutische cyclosporin-zusammensetzungen
EP2586428B1 (de) 2007-04-26 2023-11-08 Sublimity Therapeutics Limited Herstellung mehrerer Minikapseln
TW200932240A (en) * 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
ES2649112T3 (es) 2009-05-18 2018-01-10 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN107582526A (zh) 2009-08-12 2018-01-16 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CA3037762C (en) * 2014-05-15 2022-03-22 Enzychem Lifesciences Corporation Methods for treating leukopenia and thrombocytopenia
EP3881829A1 (de) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Cyclosporin enthaltende zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) * 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물

Also Published As

Publication number Publication date
ATE214937T1 (de) 2002-04-15
AR013586A1 (es) 2001-01-10
ES2175217T3 (es) 2002-11-16
HK1006780A1 (en) 1999-03-19
CN1180840C (zh) 2004-12-22
ZA975448B (en) 1999-03-19
JPH11100326A (ja) 1999-04-13
JPH107550A (ja) 1998-01-13
EP0813876A1 (de) 1997-12-29
PL188986B1 (pl) 2005-05-31
KR0183449B1 (ko) 1999-05-01
EP0813876B1 (de) 2002-03-27
PT813876E (pt) 2002-07-31
ID18517A (id) 1998-04-16
JP2855135B2 (ja) 1999-02-10
DK0813876T3 (da) 2002-07-22
JP2923503B2 (ja) 1999-07-26
DE69711267D1 (de) 2002-05-02
CO4970826A1 (es) 2000-11-07
KR980000466A (ko) 1998-03-30
CN1178106A (zh) 1998-04-08
PE97198A1 (es) 1999-01-13
DE69711267T2 (de) 2002-11-21

Similar Documents

Publication Publication Date Title
ZA975448B (en) Cyclosporin-containing soft capsule preparations
PL330869A1 (en) Non-aqueous protical peptide preparations
PL330903A1 (en) Aqueous preparations of peptides
IL139235A0 (en) Pharmaceutical preparations
AU2721897A (en) Anti-cryptosporidium parvum preparations
PL330348A1 (en) Peptidic derivatives
HUP9801109A3 (en) Cyclosporin-containing soft capsule preparations
EP0765165A4 (de) Peptide mit definierter struktur
PL328486A1 (en) Peptidic derivatives
PL318017A1 (en) Peptides
AU125644S (en) Capsule
PL340555A1 (en) Preparations containing dissolved paroxetin
GB2331521B (en) Vaccine preparations
GB9624562D0 (en) Peptide derivatives
AU3930399A (en) Cyclosporin preparations
GB9413751D0 (en) Immunodominant peptides
HUP9801021A3 (en) Cyclosporin-containing soft capsule preparations
GB9519511D0 (en) Peptides
AU5948698A (en) Cyclosporin-containing soft capsule preparations
GB9425381D0 (en) Peptides
IL111853A0 (en) Dental preparations
SG55039A1 (en) Peptides
GB9626362D0 (en) Peptides
GB9606765D0 (en) Peptides
GB9612648D0 (en) Peptides